NCT00276159 arm group adb45f8a7751fef4300c1c73f2b30d16 [clinicaltrials_resource:NCT00276159/arm-group/adb45f8a7751fef4300c1c73f2b30d16]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00276159 arm group adb45f8a7751fef4300c1c73f2b30d16 [clinicaltrials_resource:NCT00276159/arm-group/adb45f8a7751fef4300c1c73f2b30d16]
Bio2RDF identifier
NCT00276159/arm-group/adb45f8a7751fef4300c1c73f2b30d16
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... b45f8a7751fef4300c1c73f2b30d16
description [clinicaltrials_vocabulary:description]
Patients receiving at least one dose of 852A.
identifier
clinicaltrials_resource:NCT00276159/arm-group/adb45f8a7751fef4300c1c73f2b30d16
title
NCT00276159 arm group adb45f8a7751fef4300c1c73f2b30d16
@en
type
label
NCT00276159 arm group adb45f8a ...... 45f8a7751fef4300c1c73f2b30d16]
@en